News Headlines Article

In deal with big drugmaker, Sutter will test new approaches to common chronic conditions
Sacramento Business Journal

Sutter Health launched a research partnership Wednesday with drug maker AstraZeneca to work on new approaches to care for patients with diabetes, hypertension, high cholesterol and other conditions. The nonprofit health system will work with U.S.-based management of the London-based for-profit global biopharmaceutical company to design and pilot new ways to track patients and improve care. Prescription drugs that treat cardiovascular and metabolic disease are one of three major focus areas at AstraZeneca, which developed the top-selling diabetes drug Byetta and the heart drug Crestor.